Beam Therapeutics vs Envoya
Beam Therapeutics vs Envoya, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Beam Therapeutics is on 47/100 and Envoya on 46/100.
Where each one leads
Beam Therapeutics
- funding raised: $235M against $2.0M
Envoya
- domain rating: 13/100 against 0/100
At a glance
| Measure | Beam Therapeutics | Envoya |
|---|---|---|
| What it is | A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases. | Developing polymer-based nanoparticles for targeted gene therapy delivery. |
| Category | Workflows, Biotech, MedTech, Genomics | Life Sciences, Nanotechnology, Genetics, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2017 | 2021 |
| Headquarters | Cambridge, United States | San Diego, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Beam Therapeutics | Envoya |
|---|---|---|
| Employees | Not published | 10 |
| Total funding | $235M | $2.0M |
| Latest round | Series C | Pre-Seed |
| LinkedIn followers | Not published | 1,073 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Beam Therapeutics | Envoya |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 46/100 |
| Traction | 40/100 | 42/100 |
| Team | Not published | 70/100 |
| Search visibility | 2/100 | 27/100 |
| Quality | 68/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Beam Therapeutics | Envoya |
|---|---|---|
| Hosting | Not detected | Netlify |
| CDN | Not detected | Netlify |
Beam Therapeutics vs Envoya: common questions
Which is better, Beam Therapeutics or Envoya?
On our 0-100 score Beam Therapeutics rates higher (47/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Beam Therapeutics and Envoya compare on the numbers?
Beam Therapeutics leads on funding raised ($235M against $2.0M). Envoya leads on domain rating (13/100 against 0/100).
Read the full Beam Therapeutics review and pricing or the Envoya review and pricing. You can also browse other Beam Therapeutics alternatives we track.